Oral Administration of Curcumin Emulsified in Carboxymethyl Cellulose Has a Potent Anti-inflammatory Effect in the IL-10 Gene-Deficient Mouse Model of IBD
- 10 June 2009
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (5) , 1272-1277
Abstract
Curcumin is a tumeric-derived, water-insoluble polyphenol with potential beneficial health effects for humans. It has been shown to have preventive as well as therapeutic effects in chemically induced murine models of colitis. To investigate whether curcumin exerts a similar effect on the spontaneous colitis in interleukin (IL)-10 gene-deficient mice, we gavaged these mice daily for 2 weeks with 200 mg/kg per day curcumin emulsified in carboxymethyl cellulose, a food additive generally used as a viscosity modifier. Mice fed the curcumin/carboxymethyl cellulose mixture and those receiving carboxymethyl cellulose alone demonstrated similar reductions in histological injury score and colon weight/length ratio compared to water-fed controls. However, significant reductions in pro-inflammatory cytokine release in intestinal explant cultures were only seen in mice treated with the curcumin mixture. Our data demonstrate that in IL-10 gene-deficient mice, both oral curcumin and carboxymethyl cellulose, appear to have modifying effects on colitis. However, curcumin has additional anti-inflammatory effects mediated through a reduced production of potent pro-inflammatory mucosal cytokines.Keywords
This publication has 25 references indexed in Scilit:
- Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine modelFood and Chemical Toxicology, 2009
- Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protectionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiotaInflammatory Bowel Diseases, 2007
- Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental ColitisDigestive Diseases and Sciences, 2007
- Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitisInternational Immunopharmacology, 2007
- Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitisBritish Journal of Pharmacology, 2003
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cellCancer Letters, 1996
- Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell linesNutrition and Cancer, 1996
- Anti-tumour and antioxidant activity of natural curcuminoidsCancer Letters, 1995